Tagged with doing busines

MSD One of the so-called ‘new generation’ of pharmaceutical GMs in Romania outlines his first impressions of the local market and details how MSD has managed to shape in-county developments in the infectious disease segment and oncology. You have been working in the industry for 26 years and always with MSD.…

pricing The president and chairman of MC Pharma discusses the position of the pharmacy segment in the current Moroccan healthcare context.  Could you introduce MC Pharma to our international readers, and more especially describe the relationship that exists between MC Pharma and Cooper Pharma? MC Pharma was established in 2002 by…

Doing business The current negotiations for the Trans-Pacific Partnership (TPP) provide Mexico with a not-to-be-missed opportunity to review the country’s intellectual property system. The partner of the life science practice of the most important IP law firm in Mexico discusses the challenges clients from the sector face in the market place and…

doing business The director general of Promopharm explains why Hikma decided to invest in the Moroccan market, why we have to take a long-term perspective when judging the government’s reform agenda and how the main priority will always be responding to patient needs   In 2011 Hikma acquired a 63.9 percent stake…

Roche Ralf Halbach discusses the impact of low health coverage in Morocco on Roche’s strategy, and the fact that the company chose Morocco as the country to locate its northwest Africa management center.   You have been the head of Roche’s northwest Africa management center , as well as the general…

doing business The president of Genpharma talks about the challenge of producing affordable generics in Morocco, his strategy to continue growing in Africa and how his ambition is to become “the Ryanair of African pharma” How has the Moroccan pharmaceutical sector developed over the years, and what is its role within the…

doing business Mayoly Spindler wants to be an international reference in gastroenterology. The general manger of the Mexican affiliate discusses how Mexico is contributing to this goal by always being one step ahead of competitors and leveraging innovation.   Could you please introduce Mayoly Spindler to our readers? Laboratoires Mayoly Spindler is…

Bayer The director general of Bayer Maghreb explains how Morocco has real potential to position itself as a hub for the region, talks about the challenges associated with the reforms of the last two years and why as local director he has a responsibility to set the context for headquarters  …

Fresenius Following an illustrious career at Baxter, Gustavo Ambrosini moved to the Peruvian affiliate of Fresenius Medical Care. As general manager, he describes the various projects that Fresenius Medical Care is undertaking to ensure patients suffering from renal failure are adequately treated.   What were the initial priorities you set for…

UCB Tom Roberts came to UCB Korea following a position at the company’s Japanese affiliate in late 2011. He describes the market conditions for UCB’s specialty products and emphasizes the importance of valuing innovation above cost in Korea.   What have been the most notable differences between the market situations in…

Alexion Mexico is improving its regulatory framework for orphan drugs. The general manager of Alexion Mexico explains how the company is working with the authorities to ensure adequate regulation is put in place, and how Alexion is communicating with patients’ associations and medical community to raise awareness about ultra-rare diseases.  …

partnering Korea possesses enormous potential to become an exporter of futuristic health systems in the near future, and has already started the process. Kim Han-Joong, chairman of the strategy committee at CHA Health Systems, outlines Korea’s strengths in healthcare and its forward-looking vision for the future.   You became chairman of…